PMC:7096774 / 132-649
Annnotations
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 6 | 502-507 | Gene | denotes | spike | Gene:43740568 |
| 7 | 225-235 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
| 8 | 18-37 | Disease | denotes | coronavirus disease | MESH:D018352 |
| 9 | 39-47 | Disease | denotes | COVID-19 | MESH:C000657245 |
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T1 | 282-288 | Body_part | denotes | genome | http://purl.org/sig/ont/fma/fma84116 |
| T2 | 306-316 | Body_part | denotes | nucleotide | http://purl.org/sig/ont/fma/fma82740 |
| T3 | 379-387 | Body_part | denotes | antibody | http://purl.org/sig/ont/fma/fma62871 |
| T4 | 440-443 | Body_part | denotes | IgM | http://purl.org/sig/ont/fma/fma62873 |
| T5 | 448-451 | Body_part | denotes | IgG | http://purl.org/sig/ont/fma/fma62872 |
| T6 | 508-516 | Body_part | denotes | proteins | http://purl.org/sig/ont/fma/fma67257 |
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T3 | 39-47 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T4 | 225-233 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 251-256 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | virus |
| T2 | 297-298 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T1 | 306-316 | Chemical | denotes | nucleotide | http://purl.obolibrary.org/obo/CHEBI_36976 |
| T2 | 508-516 | Chemical | denotes | proteins | http://purl.obolibrary.org/obo/CHEBI_36080 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T3 | 0-93 | Sentence | denotes | The first case of coronavirus disease (COVID-19) in Finland was confirmed on 29 January 2020. |
| T4 | 94-127 | Sentence | denotes | No secondary cases were detected. |
| T5 | 128-220 | Sentence | denotes | We describe the clinical picture and laboratory findings 3–23 days since the first symptoms. |
| T6 | 221-365 | Sentence | denotes | The SARS-CoV-2/Finland/1/2020 virus strain was isolated, the genome showing a single nucleotide substitution to the reference strain from Wuhan. |
| T7 | 366-517 | Sentence | denotes | Neutralising antibody response appeared within 9 days along with specific IgM and IgG response, targeting particularly nucleocapsid and spike proteins. |